Measures | Â | Treatment visit | Â | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
 | Baseline | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | Follow-up |
Primary outcome measure | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â |
WOMACa | x | Â | Â | Â | Â | Â | Â | x | Â | Â | Â | Â | x | x |
Secondary outcome measure | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â |
Success rateb | x | Â | Â | Â | Â | Â | Â | x | Â | Â | Â | Â | x | x |
WOMAC pain(subscale) | x | x | x | x | x | x | x | x | x | x | x | x | x | x |
100 mm pain VAS on walking | x | x | x | x | x | x | x | x | x | x | x | x | x | x |
6-minute walk test | x | Â | Â | Â | Â | Â | Â | x | Â | Â | Â | Â | x | x |
IGA/PGA | x | x | x | x | x | x | x | x | x | x | x | x | x | x |